Xü Lin
Impact in
- Modeling and Simulation top 5%
- COVID-19 epidemiological studies
- Oncology top 10%
Papers in
-
- Lung Cancer Diagnosis and Treatment 5
-
- Epigenetics and DNA Methylation 4
- Co-authors
- Don Eliseo Lucero‐Prisno (25 shared papers)Yusuff Adebayo Adebisi (11 shared papers)Xin‐En Huang (8 shared papers)Attaullah Ahmadi (9 shared papers)Mohammad Yasir Essar (3 shared papers)Yan-Yan Lu (4 shared papers)Edmar Elcarte (8 shared papers)Sze Chai Chan (8 shared papers)
- Journals
- Journal of Global Health (4 papers)Frontiers in Bioengineering and Biotechnology (2 papers)Materials & Design (2 papers)Global Health Research and Policy (2 papers)Annals of Medicine (2 papers)
- Partner nations
- ChinaUnited KingdomPhilippines
In The Last Decade
Xü Lin
87 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 145
- Modeling and Simulation 72
- Oncology 258
- Health 67
- Cancer Research 110
- Pulmonary and Respiratory Medicine 224
Countries citing papers authored by Xü Lin
This map shows the geographic impact of Xü Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xü Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xü Lin more than expected).
Fields of papers citing papers by Xü Lin
This network shows the impact of papers produced by Xü Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xü Lin. The network helps show where Xü Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Xü Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 95 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 97 | |
| 2 | Influence of MDR1 gene codon 3435 polymorphisms on outcome of platinum-based chemotherapy for advanced non small cell lung cancer. | 2011 | 56 |
| 3 | 2013 | 53 | |
| 4 | 2012 | 52 | |
| 5 | 2016 | 51 | |
| 6 | 2023 | 49 | |
| 7 | 2020 | 44 | |
| 8 | 2020 | 40 | |
| 9 | 2023 | 39 | |
| 10 | 2021 | 38 | |
| 11 | 2012 | 36 | |
| 12 | 2013 | 35 | |
| 13 | 2015 | 35 | |
| 14 | 2023 | 34 | |
| 15 | 2020 | 34 | |
| 16 | 2013 | 33 | |
| 17 | 2020 | 30 | |
| 18 | Lack of any relationship between chemotherapy toxicity in non-small cell lung cancer cases and polymorphisms in XRCC1 codon 399 or XPD codon 751. | 2011 | 25 |
| 19 | 2019 | 23 | |
| 20 | 2020 | 22 |
About Xü Lin
Xü Lin is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Surgery and Epidemiology, having authored 95 papers that have together received 1.3k indexed citations. Recurring topics across this work include Legal, Health, Environmental and COVID-19 Challenges (7 papers), Lung Cancer Diagnosis and Treatment (5 papers), Diverse Scientific Research in Ukraine (4 papers), Epigenetics and DNA Methylation (4 papers), Head and Neck Cancer Studies (4 papers), Trace Elements in Health (4 papers), Environmental and Biological Research in Conflict Zones (4 papers) and Zoonotic diseases and public health (4 papers). The work is most often cited by research in Modeling and Simulation (72 citations), Oncology (258 citations), Health (67 citations), Cancer Research (110 citations) and Pulmonary and Respiratory Medicine (224 citations). Xü Lin has collaborated with scholars based in China, United Kingdom and Philippines. Frequent co-authors include Don Eliseo Lucero‐Prisno, Yusuff Adebayo Adebisi, Xin‐En Huang, Attaullah Ahmadi, Mohammad Yasir Essar, Yan-Yan Lu, Edmar Elcarte, Sze Chai Chan, Mellissa Withers and Veeleah Lok. Their work appears in journals such as Journal of Global Health, Frontiers in Bioengineering and Biotechnology, Materials & Design, Global Health Research and Policy and Annals of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.